APA (7th ed.) Citation

Knox, J. J., McNamara, M. G., Bazin, I. S., Oh, D., Zubkov, O., Breder, V., . . . Palmer, D. H. (2025). A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer. Journal of Hepatology, 83(2), 358. https://doi.org/10.1016/j.jhep.2025.01.040

Chicago Style (17th ed.) Citation

Knox, Jennifer J., et al. "A Phase III Randomized Study of First-line NUC-1031/cisplatin Vs. Gemcitabine/cisplatin in Advanced Biliary Tract Cancer." Journal of Hepatology 83, no. 2 (2025): 358. https://doi.org/10.1016/j.jhep.2025.01.040.

MLA (9th ed.) Citation

Knox, Jennifer J., et al. "A Phase III Randomized Study of First-line NUC-1031/cisplatin Vs. Gemcitabine/cisplatin in Advanced Biliary Tract Cancer." Journal of Hepatology, vol. 83, no. 2, 2025, p. 358, https://doi.org/10.1016/j.jhep.2025.01.040.